Neurology
- DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)
- MANUFACTURER: Glentek
- USAGE: Oral
- MEDICINE APPROVED BY:
- European Medical Agency (EMA)
- Therapeutic Goods Administration (TGA)
- Medicines & Healthcare products Regulatory Agency (MHRA)
- The Medicines Evaluation Board (MEB)
Glentek contains Riluzole, an FDA-approved medication that helps delay the progression of ALS by reducing the release of glutamate, a neurotransmitter that can harm nerve cells.
Read more